Ischemic stroke in children treated for acute lymphoblastic leukemia: A retrospective study

Journal of Pediatric Hematology/Oncology

Volumn 27, Issue 3, 2005, Pages 153-157

  Santoro, Nicola ^a   Giordano, Paola ^a   Del Vecchio, Giovanni Carlo ^a   Guido, Gianfranco ^a   Rizzari, Carmelo ^b   Varotto, Silvana ^c   Masera, Giuseppe ^b   De Mattia, Domenico ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

Acute lymphoblastic leukemia; Pediatric ischemic strokes

Indexed keywords

ANTICOAGULANT AGENT; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; METHOTREXATE; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BLEEDING; BRAIN VEIN; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; PHLEBOGRAPHY; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SEIZURE; SIDE EFFECT; SYMPTOMATOLOGY; VEIN THROMBOSIS;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CEREBROVASCULAR ACCIDENT; CHILD; CHILD, PRESCHOOL; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; MAGNETIC RESONANCE IMAGING; PREVALENCE; PROGNOSIS; QUESTIONNAIRES; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 15444372482     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mph.0000157379.44167.b5     Document Type: Article

References (36)

1. Kirkham FJ. Stroke in childhood. Arch Dis Child. 1999;81:85-89.
2. Schoemberg BS, Mellinger JF, Schoemberg DG. Cerebrovascular disease in infant and children. Neurology. 1978;28:763-768.
3. de Veber GA, Adams M, Andrew M. Canadian Pediatric Ischemic Stroke Registry. Thromb Haemost. 1995;73:1400.
4. de Veber G, Andrew M, Adams C, et al. Cerebral sinovenous thrombosis in children. N Engl J Med. 2001;345:417-423.
5. Lynch JK, Hirtz DG, De Veber G, et al. Report of the National Institute of Neurological Disorders and Stroke workshop on perinatal and childhood stroke. Pediatrics. 2002;109:116-123.
6. Giordano P, Santoro N, Del Vecchio GC, et al. T-immunophenotype is associated with an increased prevalence of thrombosis in children with acute lymphoblastic leukemia. A retrospective study. Haematologica. 2003;88:1079-1080.
7. Nowak-Gottl U, Wermes C, Junker R, et al. Prospective evaluation of the thrombotic risk in children with acute lymphoblastic leukemia carrying the MTHFR TT 677 genotype, the prothrombin G20210A variant, and further prothrombotic risk factor. Blood. 1999;93:1595-1599.
8. Santoro N, Giordano P, Del Vecchio GC, et al. Cerebral sinovenous thrombosis in children with acute lymphoblastic leukemia. Pathophysiol Haemost Thromb. 2003;33:104.
9. Mitchell LG. A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase. Cancer. 2003; 97:508-516.
10. Masera G, Conter V, Rizzari C, et al. AIEOP non-B ALL trials. Int J Pediatr Hematol Oncol. 1999;6:101-111.
11. Lockman LA, Mastri A, Priest JR, et al. Dural venous sinus thrombosis in acute lymphoblastic leukemia. Pediatrics. 1985;66:943-947.
12. Priest JR, Ramsay NK, Latchaw RE, et al. Thrombotic and hemorrhagic stroke complicating early therapy for childhood acute lymphoblastic leukemia. Cancer. 1980;46:1548-1554.
13. Steinherz PG, Miller LP, Ghavimi F, et al. Dural sinus thrombosis in children with acute lymphoblastic leukemia. JAMA. 1981;246:2837-2839.
14. Giordano P, Del Vecchio GC, Santoro N, et al. Thrombin generation in children with acute lymphoblastic leukemia: effect of leukemia immunophenotypic subgroups. Pediatr Hematol Oncol. 2000;17:667-672.
15. Lane DA, Grant PJ. Role of haemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood. 2000;95:1517-1531.
16. Kenet G, Sadetzki S, Murad H, et al. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke. 2000;31:1283-1288.
17. Nowak-Gottl U, Strater R, Heinecke A, et al. Lipoprotein (a) and genetic polymorphisms of clotting factor Y prothrombin and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood. Blood. 1999;94:3678-3682.
18. Zenz W, Bodo Z, Plotho J, et al. Factor V Leiden and prothiombin gene G20210A variant in children with ischemic stroke. Thromb Haemost. 1995;80:763-766.
19. Martinelli I, Sacchi E, Landi G, et al. High risk of cerebral-vein thrombosis in carriers of a prothrombin gene mutation and in users of oral contraceptives. N Engl J Med. 1998;338:1793-1797.
20. McColl MD, Chalmers EA, Thomas A, et al. Factor V Leiden, prothrombin 20210 G A, and MTHFR C677T mutations in childhood stroke. Thromb Haemost. 1999;81:690-694.
21. Bianchi D, Maeder P, Bogousslavsky J, et al. Diagnosis of cerebral venous thrombosis with routine magnetic resonance: an update. Eur Neurol. 2000;40:179-190.
22. Johnson MC, Parkerson N, Ward S. et al. Pediatric sinovenous thrombosis. J Pediatr Hematol Oncol. 2003;4:312-316.
23. Massicotte P. Low-molecular-weight heparin therapy in children. J Pediatr Hematol Oncol. 2001;23:189-194.
24. Massicotte P, Adams M, Marzinotto V, et al. Low-molecular-weight heparin in pediatric patients with thrombotic disease: a dose-finding study. J Pediatr. 1996;128:313-318.
25. Dix D, Andrew M, Marzinotto V. The use of low-molecular-weight heparin in pediatric patients. J Pediatr. 2000;136:439-445.
26. Nowak-Gottl U, Kosch A, Schleger N. Thromboembolism in newborns, infants and children. Thromb Haemost. 2001;86:464-474.
27. Chan AK, De Veber G, Monagle P, et al. Venous thrombosis in children. J Thromb Haemost. 2003;1:1443-1455.
28. Einhaupl KM, Villringer A, Meister W, et al. Heparin treatment in sinus venous thrombosis. Lancet. 1991;338:597-600.
29. Maiti B, Chakrabarti L. Study on cerebral venous thrombosis with special reference to efficacy of heparin. J Neurol Sci. 1997;150(Suppl):S147.
30. de Bruijn SF, Stam J. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke. 1999;30:484-488.
31. Monagle P, Michelson AD, Bovill E, et al. Antithrombotic therapy in children. Chest. 2001;119:344-370.
32. Von Mering M, Stiefel M, Brockmann K, et al. Deep cerebral venous sinus thrombosis often presents with neuropsychologic symptoms. J Clin Neurosci. 2003;10:310-312.
33. Buccino G, Scoditti U, Patteri I, et al. Neurological and cognitive long-term outcome in patients with cerebral venous sinus thrombosis. Acta Neurol Scand. 2003;107:330-335.
34. de Veber G, Chan A, Monagle P, et al. Anticoagulant therapy in pediatric patients with sinovenous thrombosis. Arch Neurol. 1998;55:1533-1537.
35. de Brujin SF, de Haan RJ, Stam J. Clinical features and prognostic factors of cerebral venous sinus thrombosis in a prospective series of 59 patients. J Neurol Neurosurg Psychiatry. 2001;70:105-108.
36. Lanthier S, Carmant L, David M, et al. Stroke in children. The coexistence of multiple risk factors predicts poor outcome. Neurology. 2000;54:371-378.